March 24, 2026

Certara, Inc. (CERT) Stock Analysis: Exploring a 44.69% Potential Upside Amid Healthcare Innovation

Certara, Inc. (NASDAQ: CERT), a prominent player in the healthcare sector, is drawing investor attention with a promising 44.69% potential upside, as signaled by analyst ratings...

Select Medical Holdings Corp (SEM) Stock Analysis: Evaluating Growth Potential with a Strategic Focus in Healthcare

Select Medical Holdings Corporation (NYSE: SEM) operates within the healthcare sector, specializing in medical care facilities across the United States. With a market capitalization of $2.02..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Exploring a Potential 73% Upside in the Biotech Sector

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a key player in the biotechnology sector, offers an intriguing investment narrative with its advanced pipeline of therapeutic antibodies aimed at..

LivaNova PLC (LIVN) Stock Analysis: Evaluating a 26% Upside Potential in the Medical Device Sector

LivaNova PLC (NASDAQ: LIVN), a prominent player in the medical device industry, has been capturing investor attention with its robust growth prospects and strategic positioning in..

PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: Unveiling a 24% Potential Upside

PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a pioneering name in the medical devices sector, is capturing investor attention with its innovative approach to urologic surgery. With a..

Kestra Medical Technologies (KMTS) Investor Outlook: A 46.58% Upside Potential Amidst Robust Revenue Growth

Kestra Medical Technologies, Ltd. (NYSE: KMTS) has been gaining attention in the healthcare sector, particularly among investors keen on the medical instruments and supplies industry. The..

Kiniksa Pharmaceuticals (KNSA) Stock Analysis: Strong Buy Ratings and 24.62% Potential Upside

Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA) is generating significant buzz in the healthcare sector with an enticing potential upside of 24.62%, according to recent analyst ratings...

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Strong Buy Ratings Point to 184.86% Potential Upside

Viking Therapeutics, Inc. (VKTX), a clinical-stage biopharmaceutical company, is capturing the attention of investors with its promising drug pipeline and a staggering potential upside of 184.86%...

Neogen Corporation (NEOG) Stock Analysis: Investor Outlook on Growth Potential Amid a 31.98% Upside

Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector focusing on medical devices, has caught the attention of investors with its promising growth potential...

Premier, Inc. (PINC) Stock Analysis: Navigating Challenges with 2.97% Dividend Yield

Premier, Inc. (NASDAQ: PINC), a key player in the Health Information Services industry, stands at the intersection of healthcare innovation and financial stability. With a market..

AdaptHealth Corp. (AHCO) Stock Analysis: A 24% Upside Amidst Healthcare Sector Shifts

AdaptHealth Corp. (NASDAQ: AHCO) is a company that has captured the attention of investors with its solid footing in the healthcare sector, specifically within the medical..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Capitalizing on a 28% Potential Upside in the CNS Therapeutics Market

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a biopharmaceutical company dedicated to developing and commercializing treatments for central nervous system (CNS) diseases, presents an intriguing opportunity for investors...

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Navigating Potential 31.84% Upside Despite Revenue Challenges

PTC Therapeutics, Inc. (NASDAQ: PTCT), a prominent player in the biotechnology sector, stands out with a market capitalization of $5.5 billion. Headquartered in Warren, New Jersey,..

Agios Pharmaceuticals (AGIO) Stock Analysis: Biotech Growth Potential with a 41.85% Upside

Agios Pharmaceuticals, Inc. (AGIO), a prominent player in the biotechnology sector, is capturing the attention of investors with its promising growth potential. Headquartered in Cambridge, Massachusetts,..

Mirum Pharmaceuticals, Inc. (MIRM): Investor Outlook Reveals 39% Upside Potential Driven by Robust Revenue Growth

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a burgeoning player in the biotechnology space, is capturing the attention of investors with a compelling growth narrative. With a market..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: A 49.66% Potential Upside Beckons Investors

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) presents a compelling opportunity for investors, particularly those focused on the healthcare sector. Operating within the niche of Drug Manufacturers –..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Steady Growth and Strategic Collaborations Fuel Investor Interest

Investors eyeing the healthcare sector may find Dynavax Technologies Corporation (NASDAQ: DVAX) an intriguing prospect. As a commercial-stage biopharmaceutical company with a focus on vaccine development,..

National HealthCare Corporation (NHC) Stock Analysis: A Stable Player in the Medical Care Facilities Sector

National HealthCare Corporation (NYSE: NHC) is a notable entity within the healthcare sector, specifically in the medical care facilities industry. With a market capitalization of $2.51..

CONMED Corporation (CNMD) Stock Analysis: Unpacking a 20.67% Potential Upside in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector may find CONMED Corporation (NASDAQ: CNMD) an intriguing prospect, especially given its potential upside of 20.67% according to recent..

GRAIL, Inc. (GRAL) Stock Analysis: A Promising Upside in the Diagnostics & Research Sector

For investors seeking exposure in the healthcare sector, GRAIL, Inc. (NASDAQ: GRAL) presents an intriguing opportunity. With a market capitalization of $2.02 billion, GRAIL operates in..

Search

Funds

March 24, 2026

Search

Funds

March 24, 2026

FTSE 100

Funds